Gennex Laboratories Profit & Loss Annual

BSE: 531739 | NSE: - | ISIN: INE509C01026 | Sector: Biotechnology & Drugs

19.47 +0.26 (1.35%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	86.71	65.60	61.21	59.65
Total Revenue	86.71	65.60	61.21	59.65
Costof Revenue Total	48.85	39.91	38.10	35.72
Gross Profit	37.86	25.69	23.11	23.93
Selling/ General/ Admin Expenses Total	7.79	7.87	6.97	7.21
Depreciation/ Amortization	2.37	0.92	0.79	0.88
Other Operating Expenses Total	13.04	13.12	10.76	10.19
Total Operating Expense	72.05	61.83	56.62	54.00
Operating Income	14.66	3.77	4.59	5.65
Interest Inc( Exp) Net- Non- Op Total	-30.76	-13.54	-8.77	-7.44
Other Net	4.91	3.95	1.38	0.52
Net Income Before Taxes	16.49	6.37	5.09	5.06
Provisionfor Income Taxes	3.32	1.45	1.17	1.02
Net Income After Taxes	13.18	4.92	3.92	4.04
Net Income Before Extra Items	13.18	4.92	3.92	4.04
Net Income	13.18	4.92	3.92	4.04
Income Availableto Com Excl Extra Ord	13.18	4.92	3.92	4.04
Income Availableto Com Incl Extra Ord	13.18	4.92	3.92	4.04
Diluted Net Income	13.18	4.92	3.92	4.04
Diluted Weighted Average Shares	21.67	14.61	13.26	13.26
Diluted EPS Excluding Extra Ord Items	0.61	0.34	0.30	0.30
Diluted Normalized EPS	0.61	0.34	0.30	0.33
Gain( Loss)on Saleof Assets	-	0.00	0.00	-3.71